BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20031106)

  • 1. Treatment of morbidly obese psychotic patients with molindone: three case reports.
    McCue RE; Unuigbe FE; Charles RA; Orendain GC; Waheed R
    J Clin Psychiatry; 2009 Nov; 70(11):1606-7. PubMed ID: 20031106
    [No Abstract]   [Full Text] [Related]  

  • 2. Duloxetine treatment of major depressive episodes in the course of psychotic disorders.
    Zink M; Knopf U; Mase E; Kuwilsky A; Deuschle M
    Pharmacopsychiatry; 2006 May; 39(3):109-11. PubMed ID: 16721699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of molindone in treatment-refractory agitated schizophrenia: three case reports.
    Ciranni M; Lindenmayer JP; Gold J
    J Clin Psychiatry; 2008 Jun; 69(6):1018-9. PubMed ID: 18684000
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential lower efficacy of molindone among first-generation antipsychotics.
    Waugaman RM
    Am J Psychiatry; 2009 Apr; 166(4):491; author reply 492-3. PubMed ID: 19339370
    [No Abstract]   [Full Text] [Related]  

  • 5. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
    Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
    Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication use patterns and two-year outcome in first-admission patients with major depressive disorder with psychotic features.
    Craig TJ; Grossman S; Bromet EJ; Fochtmann LJ; Carlson GA
    Compr Psychiatry; 2007; 48(6):497-503. PubMed ID: 17954133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Depressions in schizophrenic patients after the management of acute psychosis].
    Ivanets NN; Kinkul'kina MA
    Klin Med (Mosk); 2008; 86(11):53-9. PubMed ID: 19177796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molindone--a new antipsychotic drug.
    Med Lett Drugs Ther; 1975 Jul; 17(14):59. PubMed ID: 237228
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of serum molindone levels to serum prolactin levels and antipsychotic response.
    Pandurangi AK; Narasimhachari N; Blackard WG; Landa BS
    J Clin Psychiatry; 1989 Oct; 50(10):379-81. PubMed ID: 2676994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molindone hydrochloride: a review of laboratory and clinical findings.
    Owen RR; Cole JO
    J Clin Psychopharmacol; 1989 Aug; 9(4):268-76. PubMed ID: 2671060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-episode psychosis: an epidemiological survey comparing psychotic depression with schizophrenia.
    Crebbin K; Mitford E; Paxton R; Turkington D
    J Affect Disord; 2008 Jan; 105(1-3):117-24. PubMed ID: 17574683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased bone mineral density in male schizophrenia patients.
    Lehman D; Meyer JM
    Schizophr Res; 2005 Jul; 76(1):131-3. PubMed ID: 15927809
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical characteristics and length of hospital stay among older adults with bipolar disorder, schizophrenia or schizoaffective disorder, depression, and dementia.
    Sajatovic M; Friedman SH; Sabharwal J; Bingham CR
    J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):3-8. PubMed ID: 15018690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
    Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
    Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could repetitive transcranial magnetic stimulation improve neurocognition in early-onset schizophrenia spectrum disorders?
    Croarkin PE; Daskalakis ZJ
    J Am Acad Child Adolesc Psychiatry; 2012 Sep; 51(9):949-51. PubMed ID: 22917209
    [No Abstract]   [Full Text] [Related]  

  • 18. A trial of adjunctive imipramine in postpsychotic depression.
    Siris SG; Rifkin A; Reardon GT; Doddi SR; Foster P; Casey E
    Psychopharmacol Bull; 1985; 21(1):114-6. PubMed ID: 2858903
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgical treatment of morbid obesity in schizophrenic patients.
    Hamoui N; Kingsbury S; Anthone GJ; Crookes PF
    Obes Surg; 2004 Mar; 14(3):349-52. PubMed ID: 15072656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of psychotic depression].
    Kristoffersen J; Sørensen CH; Nielsen CT; Stage KB
    Ugeskr Laeger; 2008 Nov; 170(46):3753-5. PubMed ID: 19014722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.